Anthelmintic composition

A technology of repellent and anthelmintic medicine, which is applied in the directions of non-active ingredients medical preparations, organic active ingredients, anti-infective drugs, etc.
CN101107002AInactive Publication Date: 2008-01-16NORBROOK LABORATORIES LIMITED

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NORBROOK LABORATORIES LIMITED
Publication Date
2008-01-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

A topical formulation comprising as active ingredients, at least one effective agent derived from Streptomyces avermitilis, i.e. a macrocylic lactone e.g. an avermectin or chemically modified or synthetic derivative thereof, e.g. ivermectin, together with another anthelmintic of the sulphonamide type, e.g. clorsulon, in a carrier that facilitates topical administration and delivery of the active ingredients transdermal Iy, e.g. a carrier that is useful for this purpose comprises alcoholic solvents, such as ethanol, and isopropanol, with optional excipients and formulation aids, which may comprise a polymeric species such as PVP or a poloxamer.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a composition effective against Fasciola hepatica, Ostertagia ostertagi, Cooperia oncophora infections in susceptible ruminants, especially cattle. Background technique

[0002] Infection with Fasciola hepatica, Osteria austeni, and Cooperia syringae in livestock is an unresolved problem, especially in spring grazing cattle that are susceptible to infection on contaminated pastures. Injections containing ivermectin and Clorsulon are currently known methods of treatment for beef cattle and non-lactating cattle.

[0003] Closulone, a compound belonging to the benzenesulfonamide family, is recommended for the control of adult liver flukes in cattle as an oral suspension or as a subcutaneous injection. The oral dose is 7 mg / kg body weight (bw), and the subcutaneous injection is 2 mg / kg body weight. Currently, topical agents have not been developed, probably because closulone does not penetrate the skin well.

[0004] An ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More